Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Opthea Limited
Sponsor

Opthea Limited

650 Chapel Street, 3141

About the sponsor

Opthea Limited’s clinical research is centered on neovascular age-related macular degeneration (wet AMD), with studies focused on vision-threatening retinal disease and the treatment of abnormal blood vessel growth in the macula.

  • Wet AMD
  • Neovascular macular disease

The sponsor’s trials examine treatment strategies for patients with active retinal vascular disease in multiple international sites.

About Specializations

Opthea Limited runs clinical trials in conditions such as Neovascular age-related macular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neovascular age-related macular degeneration

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Opthea Limited

Neovascular age-related macular degeneration

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:Opthea Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.